Prevention of oxalate and phosphate lithiasis by alanine.
D000284:Administration, Oral; D000409:Alanine / Q000008:administration & dosage / Q000627:therapeutic use*; D000596:Amino Acids / Q000652:urine; D000818:Animals; D001835:Body Weight; D002849:Chromatography, Gas; D005260:Female; D006016:Glycolates / Q000378:metabolism; D007668:Kidney / Q000032:analysis; D007672:Kidney Cortex / Q000378:metabolism; D007679:Kidney Medulla / Q000378:metabolism; D007682:Kidney Pelvis / Q000378:metabolism; D008297:Male; D010070:Oxalates / Q000032:analysis / Q000378:metabolism* / Q000652:urine; D010710:Phosphates / Q000378:metabolism*; D011736:Pyridoxine / Q000378:metabolism; D051381:Rats; D012737:Sex Factors; D013997:Time Factors; D014513:Ureter / Q000378:metabolism; D014545:Urinary Calculi / Q000378:metabolism / Q000517:prevention & control*
D000596:Amino Acids; D006016:Glycolates; D010070:Oxalates; D010710:Phosphates; D011736:Pyridoxine; D000409:Alanine